CLDX

Celldex Therapeutics, Inc. (CLDX) is a forward-thinking biopharmaceutical company headquartered in Hampton, New Jersey, dedicated to developing innovative therapeutic monoclonal and bispecific antibodies that target significant unmet medical needs in oncology and neurology. With a strong focus on proprietary technologies that enhance both the efficacy and safety profiles of its therapies, Celldex boasts a promising pipeline of clinical programs that underscore its leadership position in targeted biologics. As the company advances its strategic initiatives, it is well-positioned to contribute to a transformative shift in treatment paradigms for patients facing critical health challenges.